Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies

B Garmezy, Brendan Curti, See full list of authors in comments

Research output: Other contribution

Original language	Undefined/Unknown
State	Published - Oct 20 2023

Name	Articles, Abstracts, and Reports

Access to Document

@misc{d89ff22c4df94ab48745138580e32598,

title = "Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies",

author = "B Garmezy and Brendan Curti and comments, {See full list of authors in}",

year = "2023",

month = oct,

day = "20",

language = "Undefined/Unknown",

series = "Articles, Abstracts, and Reports",

type = "Other",

}